Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.

Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.

Item
http://www.wikidata.org/entity/Q46346251
The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer TherapyIncreased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy.Plasma concentrations predict aortic expression of growth-arrest-specific protein 6 in patients undergoing coronary artery bypass grafting.Growth Arrest-Specific 6 Protein in Patients with Sjögren Syndrome: Determination of the Plasma Level and Expression in the Labial Salivary GlandAnalysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet's disease.Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery StudyIncomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker.The potential of genetically guided treatment in Behçet's disease.Diminished soluble levels of growth arrest specific protein 6 and tyrosine kinase receptor Axl in patients with rheumatoid arthritis.Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.Plasma growth arrest-specific protein 6 levels in premenopausal and postmenopausal women: the role of endogenous estrogen.Hypericum perforatum modulates apoptosis and calcium mobilization through voltage-gated and TRPM2 calcium channels in neutrophil of patients with Behcet's disease.
P2860

Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.

Item
http://www.wikidata.org/entity/Q46346251
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Plasma concentrations of growt ...... hematosus and Behçets disease.
@en
Plasma concentrations of growt ...... hematosus and Behçets disease.
@nl
type
label
Plasma concentrations of growt ...... hematosus and Behçets disease.
@en
Plasma concentrations of growt ...... hematosus and Behçets disease.
@nl
prefLabel
Plasma concentrations of growt ...... hematosus and Behçets disease.
@en
Plasma concentrations of growt ...... hematosus and Behçets disease.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Plasma concentrations of growt ...... hematosus and Behçets disease.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921